Results 151 to 160 of about 677,503 (281)

The Role of Somatostatin in the Gastrointestinal Tract

Biology
The gastrointestinal (GI) tract is responsible for food digestion and host protection from harmful stimuli; however, its function as an endocrine organ is also well documented. Somatostatin (SST) was first discovered in the hypothalamus, but the GI tract
Konstantinos Papantoniou, Ioanna Aggeletopoulou, Ploutarchos Pastras, Christos Triantos   +3 more
doaj   +1 more source

Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies

Journal of Clinical Endocrinology and Metabolism, 2018
A. Cozzolino, T. Feola, I. Simonelli, G. Puliani, C. Pozza, E. Giannetta, D. Gianfrilli, P. Pasqualetti, A. Lenzi, A. Isidori   +9 more
semanticscholar   +1 more source

Phosphohistone H3 and Ki‐67 as prognostic markers in metastatic small intestinal neuroendocrine tumours: A comparative, retrospective cohort study

Journal of Neuroendocrinology, Volume 38, Issue 5, May 2026.
Abstract Ki‐67 index and mitotic count form the basis of grading of small intestinal neuroendocrine tumours (siNET). We hypothesized that the mitosis‐specific marker phosphohistone H3 (PHH3) might better correlate with cancer‐specific survival (CSS) and with response to treatment. We evaluated the association between Ki‐67 index, PHH3‐estimated mitotic
Dimitrios Papantoniou, Malin Grönberg, Eva Tiensuu Janson   +2 more
wiley   +1 more source

Somatostatin Analogs in Acromegaly [PDF]

The Journal of Clinical Endocrinology & Metabolism, 2002
openaire   +2 more sources

Evaluating home injection compared with healthcare-setting injection of somatostatin analogs: a systematic literature review. [PDF]

Endocrine, 2023
Boguszewski CL, Korbonits M, Artignan A, García AM, Houchard A, Ribeiro-Oliveira A, de Herder WW.   +6 more
europepmc   +1 more source

Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors. [PDF]

Oncology, 2022
Allaw MB, Switchenko JM, Khalil L, Wu C, Alese OB, Akce M, Draper A, Jones AT, El-Rayes B, Shaib W.   +9 more
europepmc   +1 more source

Acromegaly: pathogenesis & treatment [PDF]

, 2019
Acromegaly is a multi-system disorder whose etiology is most often traced back to a growth hormone-secreting pituitary adenoma (PA). Growth hormone (GH) secretion promotes insulin-like growth factor 1 (IGF-1) release from peripheral tissues, leading to ...
Tilvawala, Megha
core  

A Real-World Observational Study of the Use and Associated Costs of Treating Neuroendocrine Tumors With Somatostatin Analogs in Canada. [PDF]

Pancreas, 2022
Cheung WY, LaForty C, Liovas A, McKechnie H, Loree JM.   +4 more
europepmc   +1 more source

The Antiproliferative Activity of High-Dose Somatostatin Analogs in Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med, 2022
Panzuto F, Ricci C, Rinzivillo M, Magi L, Marasco M, Lamberti G, Casadei R, Campana D.   +7 more
europepmc   +1 more source

Efficacy of cabergoline add-on therapy in patients with acromegaly resistance to somatostatin analogs treatment and the review of literature. [PDF]

Arch Endocrinol Metab, 2022
Kizilgul M, Duger H, Nasiroglu NI, Sencar E, Hepsen S, Akhanli P, Berker D, Cakal E, Bostan H, Ucan B.   +9 more
europepmc   +1 more source